Upcoming Webinars Archived Webinars Training Vitals Host A Webinar About Get Updates Contact

Inovio’s Zika Vaccine Enters Early Clinical Trials

XTALKS VITALS NEWS

Mosquito

The Zika vaccine candidate is the first to be approved to enter clinical trials by the US Food and Drug Administration (FDA).

Share this!

June 22, 2016 | by Sarah Massey, M.Sc.

Inovio Pharmaceuticals plans to start a Phase I clinical trial of its experimental Zika vaccine in the next few weeks. The Zika vaccine candidate is the first to be approved to enter clinical trials by the US Food and Drug Administration (FDA).

The vaccine – dubbed GLS-5700 – is being jointly developed by Pennsylvania-based Inovio pharmaceuticals and South Korea-based GeneOne Life Science. The proposed Phase I clinical trial will involve 40 healthy volunteers to test the safety and of the vaccine as well as the immune response it elicits.

Tweet: The first #Zika vaccine study in human volunteers http://ctt.ec/ri6nd+

“We are proud to have attained the approval to initiate the first Zika vaccine study in human volunteers,” said Dr. J. Joseph Kim, Inovio’s President & CEO. “As of May 2016, 58 countries and territories reported continuing mosquito-borne transmission of the Zika virus; the incidences of viral infection and medical conditions caused by the virus are expanding, not contracting. We plan to dose our first subjects in the next weeks and expect to report Phase I interim results later this year.”

According to Inovio, preclinical results for the Zika vaccine have been promising. In both small and large animal models, the experimental vaccine was capable of inducing strong antibody and T cell responses.



The Zika virus – which is spread by a mosquito vector – has been associated with severe birth defects in infants, including microcephaly. According to a recent report from the Centers for Disease Control and Prevention (CDC), the epidemic has now spread to Puerto Rico, with over 1,700 cases of the disease identified there so far.

Though the virus has yet to spread to the Southern US states, the CDC has reported that three babies born with birth defects in the US have been linked to cases of the Zika virus contracted in endemic areas.

Other drugmakers, including vaccines giant Sanofi, have Zika vaccine candidates in the pipeline, however their clinical trials are not expected to commence until 2017 at the earliest. Despite Inovio’s success so far, it could be years before their Zika vaccine completes all stages of the clinical trials process and is granted regulatory approval.


Keywords: Zika, Vaccine, Clinical Trials


| NEXT ARTICLE | MORE NEWS | BLOGS | VIDEOS | POLLS & QUIZZES | WEBINARS |

Share this with your colleagues!

MORE NEWS
New Self-Injectable Form of Lupus Drug Approved by the FDA

July 25, 2017 - Patients with systemic lupus erythematosus (SLE) will now have the option to self-inject their medication thanks to the FDA approval of GSK’s reformulated lupus drug, Benlysta (belimumab).

Featured In: Biotech News


Canadian Chicken Farmers to Further Reduce Use of Antibiotics

July 24, 2017 - The Chicken Farmers of Canada, a national group dedicated to supporting poultry farmers and helping them meet consumer demand for chicken, has announced their strategy for eliminating the use of certain antimicrobials in meat production.

Featured In: Food News


Neonatal MRI Medical Device Approved by the FDA

July 24, 2017 - Medical device maker Aspect Imaging has received US Food and Drug Administration (FDA) approval for its Embrace Neonatal MRI System.

Featured In: Medical Device News


LEAVE A COMMENT
 
  
THE XTALKS VITALS INDUSTRY BLOG

Top 5 Most Impactful Tweets from #AAIC17

REGISTER FOR THESE WEBINARS

Into the Great Wide Open: PTC’s Transformation & Global Journey to Bring Patients a First Ever Rare Disease Therapy


EDC and eSource: Combined for Better Data and Faster Insights


Using Model Reduction to Bridge the Quality Systems Pharmacology-Pharmacometrics Divide


How to Maximize Your Non-GLP Toxicology Studies: A Guide for Optimal Design and Methodology


Copyright © 2016-2017 Honeycomb Worldwide Inc.